Levothyroxine is a frequently prescribed drug in the United States, particularly for older people, as lower thyroid function can be associated with aging. Questions remain over how appropriately ...

Levothyroxine is prescribed to treat hypothyroidism—an under-active thyroid—in approximately 23 million Americans, or 7 percent of the U.S. population, under various brand names, including ...

(NewsNation) — A popular thyroid drug could be associated with bone loss according to a new study from the Radiological Society of North America (RSNA). Levothyroxine, commercially known as Synthroid ...

Abby Reinhard is a writer, editor, and native Jersey Girl. Before Best Life, she worked in medical writing, ...

A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...

A popular thyroid medication taken by 23 million Americans may be associated with bone loss, a startling new study finds. Levothyroxine — marketed under brand names such as Synthroid — is the ...

25, 2024 (HealthDay News) -- Levothyroxine (LT4) use is associated with longitudinal loss of bone mass ... Elena Ghotbi, M.D., from the Johns Hopkins University School of Medicine in Baltimore, and ...

Propensity score matching was used to match levothyroxine users to non-users based on age, gender, body mass index, baseline serum thyroid-stimulating hormone (TSH), race, medications, smoking ...

Ghotbi and colleagues aimed to determine whether levothyroxine use and higher thyroid hormone levels within the reference range are associated with higher bone loss over time in older "euthyroid ...